Editorial: NK cell subsets in health and disease: New developments

Frontiers in Immunology

Volumn 8, Issue OCT, 2017, Pages

  Marcenaro, Emanuela ^a   Notarangelo, Luigi D ^b   Orange, Jordan S ^c   Vivier, Eric ^d,e  

^a UNIVERSITY OF GENOA   (Italy)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

^d CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^e TIMONE HOSPITAL   (France)

Author keywords

Anti tumor responses; Anti viral responses; Immune checkpoints; Immunotherapy; Innate lymphoid cells; Natural killer cell subsets

Indexed keywords

CD16 ANTIGEN; CD161 ANTIGEN; CD300A ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; CD69 ANTIGEN; CD94 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR6; EOMESODERMIN; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE PROTEIN; NATURAL KILLER CELL RECEPTOR NKG2A; PERFORIN; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR; SIGLEC 7; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

CANCER IMMUNOTHERAPY; CELL ACTIVATION; CELL SUBPOPULATION; CYTOTOXICITY; DOWN REGULATION; EDITORIAL; HEMATOPOIETIC STEM CELL; HUMAN; INFLAMMATION; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; TRANSLATIONAL RESEARCH; TUMOR MICROENVIRONMENT; VIRUS INFECTION;

EID: 85031747598     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.01363     Document Type: Editorial

References (0)